BIND ABLE

Brand Owner Address Description
BINDABLE Massdrive Insurance Group 241 A. Street 4th Floor Boston MA 02210 BIND ABLE;Insurance services, providing premium rate quotes via on-line, telephone and mail means; advisory services in the field of benefits for insurance, home warranty and other protection services; advisory services in the field of affinity partner insurance for insurance, home warranty and other protection services and products;Insurance lead collection and matching services, namely, matching requests for insurance, home warranty and other protection products and services quotes collected over the internet to insurance brokers, agents and agencies interested in those requests; Promotion of insurance, home warranty and other protection products and services, on behalf of third parties;Software as a service (SAAS) services featuring software for enabling insurance agents and other marketers to quote and cross-sell multiple insurance and protection related products; designing, creating, maintaining and hosting websites concerning insurance, home warranty and other protection products and services for others;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 antagonist to a patient afflicted with such a condition. Suitable IL-4 antagonists include, but are not limited to, IL-4 receptors (such as a soluble human IL-4 receptor), antibodies that bind IL-4, antibodies that bind IL-4R, IL-4 muteins that bind to IL-4R but do not induce a biological response, molecules that inhibit IL-4-induced signal transduction, and other compounds that inhibit a biological effect that results from the binding of IL-4 to a cell surface IL-4R. Particular antibodies provided herein include human monoclonal antibodies generated by procedures involving immunization of transgenic mice. Such human antibodies may be raised against human IL-4 receptor. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.